Acromegalic arthropathy and sleep apnea

in Journal of Endocrinology

Acromegaly is associated with increased cardiovascular morbidity and mortality. However, increased growth hormone (GH) and insulin-like growth factor (IGF)-I exert deleterious effects on multiple organs and tissues and, in a direct or an indirect fashion, effect non-cardiac complications as well. The current knowledge about acromegalic arthropathy and sleep apnea will be briefly summarized here.


The articular manifestations of acromegaly were first recognized in Pierre Marie's original description of this disease in 1886. It is, perhaps, symbolic that Marie's name is connected not only with acromegaly but also with Marie-Strumpell disease (ankylosing spondylitis).

Arthropathy affects many, if not most, patients with acromegaly. In one form or another, musculoskeletal complaints are a leading cause of morbidity and functional disability in acromegaly. Several studies provided detailed epidemiologic description of acromegalic arthropathy. In the largest series of that kind, Detenbeck et al. (1973) found that 62% of the 229 patients examined had at


      Society for Endocrinology

TrendMD Widget

Index Card


All Time Past Year Past 30 Days
Abstract Views 97 97 29
Full Text Views 75 75 0
PDF Downloads 298 298 16

Altmetric Badge


Google Scholar